Home/Filings/4/0001179110-12-003649
4//SEC Filing

EBERT CHARLES D 4

Accession 0001179110-12-003649

CIK 0000884629other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 12:20 PM ET

Size

4.6 KB

Accession

0001179110-12-003649

Insider Transaction Report

Form 4
Period: 2012-02-24
EBERT CHARLES D
Sr. VP, Research & Development
Transactions
  • Tax Payment

    Common Stock, par value $0.0033

    2012-02-24$58.17/sh1,458$84,81226,264 total
Footnotes (1)
  • [F1]Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.

Issuer

WATSON PHARMACEUTICALS INC

CIK 0000884629

Entity typeother

Related Parties

1
  • filerCIK 0001241752

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 12:20 PM ET
Size
4.6 KB